-
Analysis of complications in transfemoral transcatheter aortic valve implantation: a single-center study. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2024-03-14 Anna Pyłko, Maciej Dąbrowski, Ilona Kowalik, Zbigniew Chmielak, Krzysztof Kukuła, Rafał Wolny, Jacek Kwieciński, Patrycjusz Stokłosa, Maciej Grabowski, Ilona Michałowska, Krzysztof Kuśmierski, Adam Witkowski
Transfemoral access is the prevailing approach for transcatheter aortic valve implantation (TAVI) in contemporary practice, with a shift from surgical arteriotomy to a percutaneous arterial approach.
-
Predicting acute kidney injury onset using a random forest algorithm using electronic medical records of COVID-19 patients: the CRACoV-AKI model. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2024-03-14 Katarzyna Krzanowska, Krzysztof Batko, Karolina Niezabitowska, Katarzyna Woźnica, Tomasz Grodzicki, Maciej Małecki, Monika Bociąga-Jasik, Marek Rajzer, Krzysztof Sładek, Barbara Wizner, Przemysław Biecek, Marcin Krzanowski
Acute kidney injury (AKI) is a serious and common complication of SARS-CoV-2 infection. Most risk assessment tools for AKI have been developed in the intensive care unit or elderly population. As the COVID-19 pandemic is transitioning into an endemic state, there is an unmet need for prognostic scores tailored to this population.
-
Unfractionated heparin: optimizing laboratory monitoring and reducing unwanted interference in everyday hemostasis test practice. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2024-02-19 Emmanuel J Favaloro, Leonardo Pasalic, Giuseppe Lippi
Unfractionated heparin (UFH) reflects a commonly used anticoagulant. UFH is widely utilised for a variety of reasons, including (i) to anticoagulate patients and help treat and/or prevent thrombosis, (ii) to maintain patency in artificial blood circuits, and (iii) to anticoagulate select blood samples collected for laboratory testing (typically for select biochemistry assays or blood gas analysis)
-
Greater distance between ablation lines reduces the recurrence rate after pulmonary vein isolation. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2024-02-06 Michał Peller, Mateusz Wawrzeńczyk, Piotr Ciecierski, Paweł Balsam, Michał Marchel, Bartosz Krzowski, Cezary Maciejewski, Karolina Mitrzak, Marcin Grabowski, Grzegorz Opolski, Piotr Lodziński
Pulmonary vein isolation (PVI) is a recommended strategy for rhythm control in atrial fibrillation (AF), but its success rate remains unsatisfactory. Continuous research is being conducted to explore new technologies and modifications to existing ablation workflow in order to mitigate the recurrence rate.
-
The Vulnerable Elders Survey-13 (VES-13) scale is superior to sPESI in predicting 3-month post-discharge mortality in elderly survivors of acute pulmonary embolism. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2024-01-11 Anna M Imiela, Elżbieta Kozak-Szkopek, Monika Szymańska, Katarzyna Wdowiak, Olga Dzikowska-Diduch, Aleksandra Żuk-Łapan, Andrzej Pruszczyk, Izabela Bukalska, Karolina Niewczas, Michał Machowski, Aisha Ou-Pokrzewińska, Piotr Pruszczyk
Acute pulmonary embolism (APE) is the most serious manifestation of venous thromboembolism. The Simplified Pulmonary Embolism Severity Index (sPESI) is employed for prediction of 30-day mortality in APE. The Vulnerable Elders Survey (VES-13) is used to identify participants at risk of health impairment.
-
Practical approach to a patient with a fever after travelling to the tropics. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2024-01-11 Anna Kuna, Maciej Grzybek
By 2030, an estimated two billion international tourist trips are expected annually worldwide, with Poland as an important contributor. Illness rates among returnees from developing regions hover between 43-79%. Properly diagnosing fever in these travelers is vital due to potential severe implications. After visiting tropical and subtropical zones, the main health complaints are diarrhea, fever, and
-
Obesity, cardiovascular and cerebrovascular disease: the role of GLP-1 receptor agonists. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2024-01-09 Amedeo Tirandi, Fabrizio Montecucco, Federico Carbone, Luca Liberale
Obesity prevalence is increasing dramatically worldwide, representing an important economic burden for our society. The treatment of obesity is quite challenging, potentially due to the fact that different phenotypes of the disease exist. Considering "obesities" rather than "obesity" and therefore considering different metabolism pathophysiology might help to better identify more tailored treatments
-
Popular diets and nutritional assessment in the management of irritable bowel syndrome in inflammatory bowel disease: an overview of current evidence. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2024-01-09 Carlo Covello, Guia Becherucci, Franco Scaldaferri, Lucrezia Laterza, Antonio Gasbarrini, Maria Chiara Mentella
There is increasing interest in using popular diets to manage inflammatory bowel diseases (IBD), such as ulcerative colitis (UC) and Crohn's disease (CD). These conditions are often associated with nutritional deficiencies, protein-energy malnutrition, micronutrient malnutrition, altered body composition, and sarcopenia. While dietary interventions can be supportive in treating intestinal symptoms
-
Factors influencing body weight changes in Polish adults over 60 years old during the COVID-19 era. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-11-29 Michail Chourdakis,Xenophon Theodoridis
-
Hepatic perivascular epithelioid cell neoplasm in a 58-year-old woman. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-11-27 Xin-Liang Liu,Jing Cui,Hu Tian
-
Unexpected 131I iodine scintigraphy finding: Warthin's tumor in a patient with toxic nodular goiter referred for radioiodine treatment. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-11-27 Aleksandra Aulich,Paweł Cichocki,Borys Stefański,Zbigniew Adamczewski
-
Recent guidelines addressing chronic rhinosinusitis with nasal polyps: practical aspects. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-11-21 Matthew A Rank,Alex M Wonnaparhown,Catherine M Freeman
Chronic rhinosinusitis (CRS) is common in adults. It is diagnosed based on a high index of suspicion alongside objective means of assessing sinus inflammation. Determining the impact of CRS on patient quality of life is an important starting point for discussions regarding treatment, and is critical for longitudinal assessment of response to specific treatments. CRS can be further categorized by the
-
Reduced-dose apixaban in cancer-associated thrombosis: a single center experience. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-11-20 Anna Werońska,Anetta Undas,Ewa Wypasek
-
Changes in serum oxylipin profile after one anastomosis gastric bypass. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-11-20 Alicja Pakiet,Paulina Łukaszewicz,Monika Proczko-Stepaniak,Łukasz Kaska,Adriana Mika
-
ChatGPT fails the Polish board certification examination in internal medicine: artificial intelligence still has much to learn. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-11-20 Szymon Suwała,Paulina Szulc,Aleksandra Dudek,Aleksandra Białczyk,Kinga Koperska,Roman Junik
-
18F-fluorodeoxyglucose and 18F-sodium fluoride positron emission tomography imaging in assessing early stages of aortic valve degeneration after transcatheter aortic valve implantation. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-11-15 Danuta Sorysz,Artur Dziewierz,Marta Opalinska,Anna Sowa-Staszczak,Anna Grochowska,Krzysztof P Malinowski,Natalia Maruszak,Stanisław Bartuś,Dariusz Dudek
INTRODUCTION Transcatheter aortic valve implantation (TAVI) is a standard treatment for severe aortic stenosis, primarily in elderly patients. With increasing procedures and younger patients, understanding valve degeneration and its risk factors becomes crucial. OBJECTIVES We aimed to utilize 18F-sodium fluoride (18F-NaF) and 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)-computed
-
Severe course of type IV Takayasu disease during treatment with etanercept. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-11-14 Izabela Łoń,Łukasz Leśnowolski,Izabela Janiec,Magdalena Januszewicz,Piotr Sobieraj,Jacek Lewandowski
-
A middle-aged man with total anomalous pulmonary venous connection. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-11-11 Yuanhao Xia,Xinyu Yang,Zehua Sun,Hao Guo,Xianglin Li,Heng Ma
-
Microvascular dysfunction in hypertrophic cardiomyopathy: the diagnostic role of non-invasive, fully automated quantitative perfusion cardiovascular magnetic resonance imaging. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-11-08 Sonia Borodzicz-Jazdzyk,Geoffrey W de Mooij,Ramon B van Loon,Marco J W Götte
-
D-Dimers in diagnosis and prevention of venous thrombosis: recent advances and their practical implications. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-11-08 Benilde Cosmi,Cristina Legnani,Alessia Libra,Gualtiero Palareti
D‑Dimers derive from degradation of cross‑linked fibrin by plasmin, and thus their level is a marker of coagulation and fibrinolytic system activation. Guidelines recommend that D‑dimers are determined if the pretest probability (PTP) is low or intermediate, to exclude venous thromboembolism (VTE), either deep vein thrombosis or pulmonary embolism, and to avoid imaging tests. If the PTP is high or
-
Collision sellar lesion: coexistence of growth hormone - secreting pituitary neuroendocrine tumor and pituicytoma. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-11-06 Małgorzata Woźniak,Tomasz A Dziedzic,Tomasz Gotlib,Magdalena Góralska,Maria Maksymowicz,Ewa Matyja
-
Peripartum cardiomyopathy requiring heart transplantation, complicated by disseminated aspergillosis and superior vena cava syndrome. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-11-06 Justyna M Sokolska,Magdalena Pszczołowska,Katarzyna Logoń,Magdalena Cielecka,Mateusz Sokolski,Michał Zakliczyński
-
Extensive cardiac damage due to Streptococcus sanguinis infective endocarditis in a patient with complex congenital heart disease. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-11-06 Karolina Plaskota,Aleksander Szczęsny,Magdalena Kumor,Ilona Michałowska,Piotr Hoffman,Mirosław Kowalski
-
Rare and unusually massive left ureteroinquinal and scrotal hernia. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-11-06 Rafał Celiński,Ewa Kurys-Denis,Anna Grzywa-Celińska
-
-
Smoking in antineutrophil cytoplasmic antibody-associated vasculitis: from disease susceptibility to long-term prognosis. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-10-26 Gianmarco Lugli,Francesco Peyronel,Augusto Vaglio
-
A fatal course of pancreatic pseudocyst rupture: reflections on the management of the patient. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-10-26 Edyta Niemiec,Robert Staron,Marcin Krawczyk,Łukasz Krupa
-
A fatal course of pancreatic pseudocyst rupture: reflections on the management of the patient. Authors' reply. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-10-26 Agata Janoska-Gawrońska,Marta Pietrukaniec,Milena Kopyś-Sikora,Monika Niezgoda,Michał Holecki
-
The role of smoking in antineutrophil cytoplasmic antibody-associated vasculitis: time to highlight the importance of smoking cessation interventions. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-10-26 Micaela Gentile,Giovanni M Rossi
-
Global approach to patients with heart failure: everything matters. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-10-26 Francesc Formiga,David Chivite,Prado Salamanca-Bautista
-
The role of high-resolution computed tomography in diagnosing pneumonia caused by Legionella pneumophila. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-10-24 Wiesław Guz,Kinga Kolarska,Agnieszka Gala-Błądzińska
-
Giant uterine fibroid and adrenal tumor in patient who ceased congenital adrenal hyperplasia treatment. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-10-24 Dorota Leszczyńska,Agata Tuszyńska-Meissner,Michał Ciebiera,Marta Włodarczyk,Wojciech Zgliczyński
-
Combined renal small cell carcinoma: an extremely rare and unexpected case. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-10-24 Magdalena Chrabańska,Jakub Ryszawy,Bogna Drozdzowska
-
The role of antithyroid antibodies in thyroid dysfunction after allogeneic hematopoietic stem cell transplantation. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-10-24 Magdalena Rajner,Marcin Jasiński,Ewa Karakulska-Prystupiuk,Urszula Ambroziak,Wiesław W Jędrzejczak,Grzegorz W Basak
-
Cladribine treatment in patients with pulmonary Langerhans cell histiocytosis. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-10-18 Elżbieta Radzikowska,Jacek Wakuliński,Renata Langfort,Mirosław Dziuk,Stefan Wesołowski,Katarzyna Błasińska
-
A case of legionnaires' disease during the legionella epidemic in south-eastern Poland in August 2023. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-10-11 Mateusz Szymański,Jakub H Śmietana,Wiktor R Jaworski,Małgorzata M Skiba,Małgorzata Piasecka,Alina Olender
-
Primary aldosteronism 2.0: an update for clinicians on diagnosis and treatment. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-10-11 Stefan Pilz, Tomaz Kocjan, Verena Theiler-Schwetz, Christian Trummer
Primary aldosteronism (PA), characterized by inappropriately high concentrations of the adrenal derived hormone aldosterone, is the most common endocrine cause of arterial hypertension. Compared to essential hypertension, patients with PA have a significantly increased cardiovascular risk that cannot be fully reversed by common antihypertensive treatment because of blood pressure independent deleterious
-
Co‑occurrence of granulomatosis with polyangiitis and a lung carcinoid tumor. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-10-10 Fabian Kosko,Alicja Dębska-Ślizień,Piotr Skonieczny,Wojciech Wołyniec,Sławomir Lizakowski,Zbigniew Heleniak
-
Pain treatment and risk associated with the use of analgesics on admission to the internal medicine ward: a prospective observational study. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-10-05 Aleksandra Sesiuk,Aleksandra Kotlińska-Lemieszek,Tomasz Grądalski
-
Metastatic colon cancer in an elderly woman manifesting as hypopituitarism and vision loss. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-10-05 Maryla Kuczyńska,Małgorzata Matuszek,Jan Sobstyl,Anna Drelich-Zbroja
-
Alterations of the kynurenine pathway in patients with type 1 diabetes are associated with metabolic control of diabetes. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-10-05 Małgorzata Kiluk,Janina Lewkowicz,Irina Kowalska,Dariusz Pawlak,Katarzyna Łagoda,Anna Tankiewicz-Kwedlo
-
A rare case of continuous upper gastrointestinal hemorrhage with chronic pancreatitis. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-10-04 Jin-Hui Yi,Yu Liu,Jin-Jie Xu,Liang-Hao Hu
-
A 37-year-old woman with schwannomatosis, who has undergone 10 neurosurgical procedures: the first case in Poland with the SMARC1B gene mutation. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-10-03 Sara Zięba,Bogdan Czapiga,Paweł Gajdzis,Joanna Bladowska
-
Remarkable regression of inoperable pancreatic grade 3 neuroendocrine neoplasm after radioligand therapy with [177Lu]Lu-DOTATATE and [90Y]Y‑DOTATATE. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-10-02 Adam D Durma,Marek Saracyn,Maciej Kołodziej,Katarzyna Jóźwik-Plebanek,Grzegorz Kamiński
-
The use of iodine-based contrast materials in computed tomography and the risk of thyroid disease: what should a general practitioner know? Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-09-29 Katarzyna Ziemnicka
-
Unraveling the smoker's paradox: impact of smoking on outcomes in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-09-29 Derek J Hausenloy,Ching-Hui Sia,Junsuk Ko
-
Bias in data analysis of the study "Effectiveness of the BNT162b2 vaccine in preventing COVID-19-associated deaths in Poland". Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-09-29 Paweł Zagożdżon
-
Effectiveness of the BNT162b2 (COMIRNATY) vaccination in protecting from death due to COVID-19 in Poland: epidemiologic commentary and limitations. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-09-29 Andrzej Jarynowski
-
Authors' reply to the letters concerning the article "Effectiveness of the BNT162b2 vaccine in preventing COVID-19-associated deaths in Poland". Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-09-29 Łukasz Pietrzak,Kamil Polok,Rafał Halik,Agnieszka Szuster-Ciesielska,Wojciech Szczeklik
-
Rapidly progressive streptococcal toxic shock syndrome epidemic in Kraków, 2023. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-09-22 Jacek Górka,Wojciech Skupnik,Maciej Mikiewicz,Kinga Szwajca,Katarzyna Haładus,Wojciech Szczeklik
-
Severe skeletal damage suggesting neoplastic disease as a manifestation of tenofovir-induced Fanconi syndrome in chronic hepatitis B. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-09-22 Ksymena Leśniak,Hanna Behrendt,Anna Bieda,Stanisław Niemczyk
-
When malaria imitates thrombotic thrombocytopenic purpura: importance of patient history and physician awareness of uncommon diseases. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-09-21 Michał Kurek,Paweł Pasieka,Anna Włudarczyk,Wojciech Szczeklik
-
Subcutaneous emphysema of the lower extremity and pneumoperitoneum after endoscopic retrograde cholangiopancreatography-related duodenal perforation. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-09-21 Wiktoria Feret-Adrabińska,Jan Wojciechowski,Tomasz Skołozdrzy,Aleksandra Daniel,Katarzyna Gaweł,Andrzej Białek
-
Avoiding medical futility in patients dying in a hospital: a position statement of the Polish Society of Internal Medicine Working Group on Medical Futility at Internal Medicine Units. Part 1: A dying patient who is not legally incapacitated but is incapable of making informed decisions regarding treatment that is considered medically futile. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-09-21 Wojciech Szczeklik,Małgorzata Krajnik,Jakub Pawlikowski,Małgorzata Szeroczyńska,Piotr Gajewski,Aleksandra Kotlińska-Lemieszek,Piotr Aszyk,Andrzej Muszala,Jacek Imiela,Tomasz Imiela,Jacek Górka,Andrzej Kübler,Radosław Owczuk,Jan Duława
-
Who may benefit from low-dose Rivaroxaban plus Aspirin? Practical implications for outpatients with cardiovascular disease. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-09-21 Leonardo De Luca
Despite the availability of effective preventive therapies based on guidelines, patients with vascular diseases continue to be at a high risk for recurrent ischemic events. Therefore, novel therapeutic strategies are required to further reduce the residual risk present in these patients at high risk. Platelet aggregation and fibrin organization are involved in arterial thrombosis, and rivaroxaban is
-
May-Thurner syndrome as the cause of recurrent venous thromboembolism in a young woman: the role of multidisciplinary treatment. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-09-20 Sylwia Sławek-Szmyt,Michał Łączak,Joanna Grygier,Zbigniew Krasiński,Michał-Goran Stanišić,Aleksander Araszkiewicz
-
Bilateral ischemic stroke in a 37-year-old patient with factor V Leiden mutation and arrhythmogenic right ventricular dysplasia. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-09-20 Maryla Kuczyńska,Monika Zbroja,Katarzyna Drelich,Olga Pustelniak,Mariusz Kozak,Edyta Opalińska
-
Iatrogenic injury of the inferior vena cava during hemodialysis catheter implantation. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-09-19 Adam Płoński,Adam F Płoński,Tomasz Hryszko,Jerzy Głowiński
-
18F-FDG-PET/CT imaging of aseptic abscess syndrome mimicking metastatic disease or granulomatosis. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-09-19 Mathilde Masse,Micheline Razzouk-Cadet
-
When standard cardiac diagnostics fail: the key role of the Apple Watch in confirming the diagnosis of pacemaker ventricular lead damage. Pol. Arch. Intern. Med. (IF 5.218) Pub Date : 2023-09-19 Maja Hawryszko,Grzegorz Sławiński,Piotr Zieleniewicz,Szymon Budrejko,Ludmiła Daniłowicz-Szymanowicz,Maciej Kempa